Selenoprotein P treatment induces glucose intolerance and insulin resistance, whereas hepatic knockdown of selenoprotein P improved glucose intolerance and insulin resistance (Misu et al., 2010). This evidence concerns the gene SELENOP and Glucose intolerance.